Bristol Myers Squibb (BMY) Stock Price & AI Analysis
NYSE
$59.38
$1 (1.49%)
Subscribe to get AI Score
Market Cap 121.54B
Volume
7.28M
Avg Volume
11.05M
Target Price $52.25
52W Range
39.35 - 61.08
RSI (14) 60.83
Beta 0.44
PEG Ratio 0
SMA 20
1.73
SMA 50
7.36
SMA 200
21.31
Insider Owner 0.08%
Insider Trans 0.07%
Institution Owner 77.73%
Institution Trans 0.47%
Short Interest 25.77%
EPS next Y 686.02
Bristol Myers Squibb Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Analyst recommendations
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for wealth-building investments. With that...
Following Wednesday's trade, Jim Cramer's Charitable Trust will own 800 shares of BMY, increasing its weighting to about 1.25% from 1%. Shares of pharmaceutical maker Bristol-Myers have dropped ...
Free Report) . Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important ...